您要查找的是不是:
- Proline-rich tyrosine kinase 2 富脯氨酸蛋白酪氨酸激酶
- The name is soluble f-m-s-like tyrosine kinase one? 这种蛋白质叫做可溶解fms样酪氨酸激酶一,
- Objective To assess the effect of tyrosine kinase inhibitor (2,5-MC) on the inhibition of in-stent inti-mal hyperplasia. 目的评估酪氨酸蛋白激酶抑制剂2,5-MC抑制支架植入术后内膜增殖的效果。
- Is PDGF tyrosine kinase inhibitor effective in pancreatic cancer? PDGF受体酪氨酸激酶抑制剂在胰腺癌中是否有作用?
- Objective:To determine the expression of angiopoietin 1(Ang 1),angiopoietin 2(Ang 2) and tyrosine kinase receptor Tie 2 in glioma and assess the role of angiogenesis. 目的 :通过对胶质瘤的促血管生成素 1 (Angiopoietin 1 ,Ang 1 )和促血管生成素 2 (Angiopoietin 2 ,Ang 2 )及酪氨酸激酶受体 (Tie 2 )mRNA表达的检测 ,初步探讨它们与胶质瘤血管生成的关系及临床意义。
- The inhibitor of VEGF receptor tyrosine kinase was introduced in detail. 详细介绍了VEGF受体酪氨酸激酶抑制剂的研究进展。
- Sunitinb is a novel multitargeted receptor tyrosine kinase inhibitor. 苏尼替尼是一种新型的多靶点酪氨酸激酶抑制剂。
- The ABL gene encodes a tyrosine kinase whose activity is tightly regulated. ABL基因编码一种活性受到严格调控的酪氨酸激酶。
- The proline rich helix, glycine rich helix, and importance of these residues and water molecules in forming the higher order structure of collagen fibers. 贝它褶板的成份对丝蛋白的强度、弹性与伸缩性的关连性。丝蛋白的丝心蛋白的基因编码。
- FGFR3, a member of polypeptide growth factor family, is a tyrosine kinase receptor. FGFR3是这一多肽类生长因子的家族成员之一,它是一种酪氨酸激酶受体。
- The progress in tyrosine kinase inhibitor has been reviewed, including the chemical structures and the pharmacophore models. 本文综述了近年来酪氨酸激酶抑制剂的研究进展,包括抑制剂的结构和与激酶作用的药效团模型。
- Isoflavone. Inhibitor of EGFR tyrosine kinase, blocking phosphatidylinositol turnover. 异黄酮类。抑制EGFR酪氨酸激酶。阻断磷脂酰肌糖的翻转。
- STI571 could induce leukemia cells of ANLL into terminal differentiation by inhibiting c-kit tyrosine kinase. STI571对急性非淋巴细胞白血病原代细胞有诱导向同系终末分化的作用,对c-kit酪氨酸激酶有明显的抑制作用,且与药物浓度相关。
- Objective:To study the expressions and the clinical significance of cyclin E and cyclin-dependent kinase 2 (cdk2) in bladder transitional cell carcinoma. 探讨细胞周期蛋白E(cyclinE)和细胞周期蛋白依赖性激酶 2 (cdk2 )与膀胱癌发病的关系及其临床意义。
- Objective:To explore the mutation of receptor tyrosine kinase ( RET ) gene in sporadic medullary thyroid carcinoma. 目的:研究散发型甲状腺髓样癌酪氨酸激酶受体基因(RET)的突变情况。
- OBJECTIVE:To discuss the progress and the clinical application evaluation of protein tyrosine kinase(PTK) inhibitors. 目的:探讨酪氨酸激酶抑制剂的进展与临床应用评价。
- Objective:To investigate the expressions and significance of cyclin-dependent kinase 2 (CDK2) and heat shock protein 60 (HSP 60) in human cervical carcinoma. 目的 :研究人子宫颈癌组织中细胞周期蛋白依赖性激酶 (CDK) 2、热休克蛋白 (HSP) 60的表达状态 ,并探讨它们与宫颈癌的关系。
- The structures and functions of EGFR as well as current status of EGFR tyrosine kinase inhibitors are reviewed. 综述了EGFR的结构和作用以及近年来EGFR酪氨酸激酶抑制剂的研究进展。
- Objective To explore the change rule of G protein coupled receptor kinase 2(GRK2) in the lung tissue of rats with acute lung injury(ALI) induced by lipopolysaccharide (LPS). 目的探讨脂多糖(LPS)诱导急性肺损伤(ALI)大鼠肺组织G蛋白偶联受体激酶2(GRK2)的变化规律。
- Trastuzumab is a monoclonal antibody that directly targets part of the HER2 tyrosine kinase receptor. 曲妥单抗是一种直接针对HER2酪氨酸激酶受体的单抗。